Rituximab Therapeutic Cheat Sheet
Rituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other …
Rituximab was the first monoclonal antibody approved for cancer treatment and now in dermatology, this medication has been life-altering for patients with the severe, autoimmune blistering disease, pemphigus vulgaris. We continue our series, Therapeutic Cheat Sheet, with a closer look at rituximab, which is FDA-approved for the treatment of pemphigus vulgaris, and is also used off label for other … 
Wow! Prior to my attendance to the 2020 Skin of Color Virtual Conference, I had not fully realized the deficits in my learning when it came to recognizing common dermatologic conditions in our skin of color (SOC) patient population. Prior to Dr. Ted Rosen’s lecture on rosacea in SOC patients I had figured I knew enough to identify this dermatologic condition in most clinical settings as well as … 
Each month the JDD Dermatology Podcast discusses a current issue in dermatology and this December Dr. Adam Friedman sat down with Dr. Gideon Smith, assistant professor of dermatology at Harvard Medical school, Vice Chair for Clinical Affairs in Dermatology, and Director of the Connective Tissue Diseases Clinic and Fellowship to discuss pruritus in the autoimmune connective tissue world.
Dr. … 
Welcome back to another installment of Therapeutic Cheat Sheet – the series where we break down complex therapeutics into an easy-to-use reference. This month, we turn our focus to hydroxychloroquine and other antimalarials. While this versatile class of drugs has been in use for decades, recent updates to monitoring recommendations have made their use easier than before. Here’s what you ne … 